GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ExpreS2ion Biotech Holding AB (OSTO:EXPRS2) » Definitions » Issuance of Debt

ExpreS2ion Biotech Holding AB (OSTO:EXPRS2) Issuance of Debt : kr0.00 Mil (TTM As of Mar. 2024)


View and export this data going back to 2016. Start your Free Trial

What is ExpreS2ion Biotech Holding AB Issuance of Debt?

ExpreS2ion Biotech Holding AB's Issuance of Debt for the three months ended in Mar. 2024 was kr0.00 Mil.

ExpreS2ion Biotech Holding AB's Issuance of Debt for the trailing twelve months (TTM) ended in Mar. 2024 was kr0.00 Mil.

ExpreS2ion Biotech Holding AB Issuance of Debt Historical Data

The historical data trend for ExpreS2ion Biotech Holding AB's Issuance of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ExpreS2ion Biotech Holding AB Issuance of Debt Chart

ExpreS2ion Biotech Holding AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Issuance of Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.50 6.34 - - -

ExpreS2ion Biotech Holding AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Issuance of Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

ExpreS2ion Biotech Holding AB Issuance of Debt Calculation

Issuance of Debt represents all the cash inflow from debt, including both long-term debt and short-term debt.

Issuance of Debt for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ExpreS2ion Biotech Holding AB Issuance of Debt Related Terms

Thank you for viewing the detailed overview of ExpreS2ion Biotech Holding AB's Issuance of Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

ExpreS2ion Biotech Holding AB (OSTO:EXPRS2) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ExpreS2ion Biotech Holding AB (OSTO:EXPRS2) » Definitions » Issuance of Debt
Comparable Companies
XSAT:ABERA NGM:COEGIN OSTO:COMBI OSTO:SCOL OSTO:LPGO OSTO:BIOSGN XSAT:CHOSA OSTO:2CUREX XSAT:RESP XSAT:APTA OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
5JD:Germany
Address
c/o Mindpark, Ronnowsgatan 8c, Helsingborg, SWE, S-252 25
Website
https://www.expres2ionbio.com
ExpreS2ion Biotech Holding AB has developed a technology platform, ExpreS2, for fast and efficient non-clinical development and production of complex proteins for new vaccines and diagnostics. ExpreS2 is regulatorily validated for clinical supply. The platform includes functionally modified glycosylation variants for enhanced immunogenicity and pharmacokinetics. The company has produced more than 500 proteins and virus-like particles (VLPs) in collaboration with research institutions and companies.

ExpreS2ion Biotech Holding AB (OSTO:EXPRS2) Headlines

No Headlines